SMT Chosen as Exclusive Distributor of Penumbra’s Latest Mechanical and Computer-Aided Aspiration Technology in India to Address Blood Clots in the Heart and Body

Business Wire IndiaSMT announced today that it has been selected as the exclusive distributor of Penumbra’s peripheral and coronary vascular thrombectomy technologies in select domestic geographies in India. Under the terms of the agreement, SMT will provide healthcare providers with Penumbra’s latest Indigo® System portfolio, including CATTM RX, which recently received India CDSCO (Central Drug Standard Control Organization) approval, and Lightning® technologies, upon regulatory approval, to address conditions such as coronary thrombosis, venous thrombosis, arterial thrombosis and pulmonary embolism.  

Penumbra is a global healthcare company focused on innovative therapies. SMT, a global medical device player with market leadership in coronary vascular devices, is thrilled about the new partnership. “We are honored to have the opportunity to partner with Penumbra as we believe that this partnership will be a great success and bring innovative products to patients in India,” said SMT India business Head Mr. Amod Bhave.

Penumbra’s Indigo System portfolio is designed for single session blood clot removal in peripheral arterial and venous systems, including the treatment of pulmonary embolism, and now with Lightning Aspiration Tubing, is the first and only computer-aided mechanical aspiration technology that can differentiate between clot and blood, which is designed to minimize blood loss. Additionally, Penumbra’s Indigo System CAT RX is designed for safe and efficient blood clot removal from the coronary and peripheral vasculature.